Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
The British Journal of Radiology|June 1, 1979
The treatment of difficult cutaneous basal and squamous cell carcinomata with electronsE Grosch, H E LambertClinical Oncology (Royal College of Radiologists (Great Britain))|March 1, 1992
Solitary cerebral metastases from gynaecological malignancy: the case for radical therapyH Thomas, H E LambertBritish Medical Journal (Clinical Research Ed.)|March 23, 1985
High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative GroupH E Lambert, R J BerryClinical Radiology|January 1, 1987
Subclavian and axillary vein thrombosis following radiotherapy for carcinoma of the breastC B Wilson, H E Lambert, R D ScottClinical Radiology|September 1, 1986
Combined radiotherapy and chemotherapy for advanced carcinoma of the cervixP R Blake, A N Branson, H E LambertEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Savings obtained by CA-125 measurements during therapy for ovarian carcinoma. The North Thames Ovary GroupG J Rustin, A Nelstrop, J Stilwell, et al.The British Journal of Radiology|June 1, 1985
A device for interstitial therapy of low pelvic tumours--the Hammersmith perineal hedgehogA N Branson, P Dunn, K C Kam, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group StudyG J Rustin, A E Nelstrop, M K Tuxen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group studyH E Lambert, G J Rustin, W M Gregory, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group StudyH E Lambert, G J Rustin, W M Gregory, et al.Pageof 3